摘要:
Methods of using compounds which are progesterone receptor agonists for contraception and the treatment of progesterone-related maladies alone or in combination with an estrogen receptor agonist or progesterone receptor antagonist are provided. These compounds have the structure: wherein R1, R2, R3, R4, R5, and Q1 are defined herein.
摘要:
This invention relates to substituted indoline derivative compounds which are antagonists of the progesterone receptor, their preparation and pharmaceutical utility, particularly including contraception and treatment of benign or malignant neoplastic diseases, having the general structure: wherein R1 and R2 may be single substituents or fused to form spirocyclic rings.
摘要:
This invention relates to substituted indoline derivative compounds which are antagonists of the progesterone receptor, their preparation and pharmaceutical utility, particularly including contraception and treatment of benign or malignant neoplastic diseases, having the general structure: wherein R1 and R2 may be single substituents or fused to form spirocyclic rings.
摘要翻译:本发明涉及作为孕酮受体拮抗剂的取代二氢吲哚衍生物化合物,其制备方法和药物应用,特别是包括具有以下一般结构的良性或恶性肿瘤疾病的避孕和治疗:其中R 1和 R 2可以是单个取代基或稠合形成螺环。
摘要:
This invention relates to compounds which are agonists of the progesterone receptor which have the general structure: wherein: R1, R2, R3, R4, R5 and Q1 are as defined herein, or a pharmaceutically acceptable salt thereof, as well as methods of using these compounds to induce contraception or treat progesterone-related carcinomas and adenocarcinomas.
摘要:
This invention relates to methods of co-administering compounds of formula 1 which are agonists of the progesterone receptor which have the general structure: wherein: R1, R2, R3, R4, R5 and Q1 are as defined herein, or a pharmaceutically acceptable salt thereof, with estrogen, an estrone, or an estrogen receptor agonist for contraception, hormone replacement therapy, or treating progesterone-related carcinomas and adenocarcinomas.
摘要翻译:本发明涉及共同施用式1化合物的方法,其为具有以下通式结构的孕酮受体的激动剂:其中:R 1,R 2,R 2, R 3,R 4,R 5和Q 1如本文所定义,或其药学上可接受的盐,与 雌激素,雌激素或雌激素受体激动剂用于避孕,激素替代治疗或治疗孕激素相关的癌和腺癌。
摘要:
This invention provides a progesterone receptor antagonist of formula 1 having the structure wherein, T is O, S, or absent; R1, and R2 are each, independently, hydrogen, alkyl, substituted alkyl; or R1 and R2 are taken together form a ring and together contain —CH2(CH2)nCH2—, —CH2CH2CMe2CH2CH2—, —O(CH2)pCH2—, —O(CH2)qO—, —CH2CH2OCH2CH2—, or —CH2CH2NR7CH2CH2—; n=1-5; p=1-4; q=1-4; R3 is hydrogen, OH, NH2, alkyl, substituted alkyl, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, or CORA; RA is hydrogen, alkyl, substituted alkyl, alkoxy, substituted alkoxy, aminoalkyl, or substituted aminoalkyl; R4 is hydrogen, halogen, CN, NH2, alkyl, substituted alkyl, alkoxy, substituted alkoxy, aminoalkyl, or substituted aminoalkyl; R5 is hydrogen, alkyl, or substituted alkyl; R6 is hydrogen, alkyl, substituted alkyl, or CORB; RB is hydrogen, alkyl, substituted alkyl, alkoxy, substituted alkoxy, aminoalkyl, or substituted aminoalkyl; R7 is hydrogen or alkyl; or a pharmaceutically acceptable salt thereof.
摘要翻译:本发明提供具有以下结构的式1的孕酮受体拮抗剂,其中T为O,S或不存在; R 1,R 2和R 2各自独立地为氢,烷基,取代的烷基; 或R 1和R 2一起形成环,并且一起含有-CH 2(CH 2)2 CH 2 CH 2 - , - CH 2 CH 2 CH 2 CH 2 N 2 CH 2 2 CH 2 - , - O(CH 2)2 CH 2 - , - (CH 2 CH 2) O(CH 2 CH 2)q O - , - CH 2 CH 2 OCH 2 - / SUB CH 2,或CH 2 CH 2,NR 7,CH 2,CH 2, CH 2 - ; n = 1-5; p = 1-4; q = 1-4; R 3是氢,OH,NH 2,烷基,取代的烷基,烯基,取代的烯基,炔基,取代的炔基或COR A。 R A是氢,烷基,取代的烷基,烷氧基,取代的烷氧基,氨基烷基或取代的氨基烷基; R 4是氢,卤素,CN,NH 2,烷基,取代的烷基,烷氧基,取代的烷氧基,氨基烷基或取代的氨基烷基; R 5是氢,烷基或取代的烷基; R 6是氢,烷基,取代的烷基或COR B; R B是氢,烷基,取代的烷基,烷氧基,取代的烷氧基,氨基烷基或取代的氨基烷基; R 7是氢或烷基; 或其药学上可接受的盐。
摘要:
Organic electroluminescent device can be formed with multiple layers including an electrode, an emission layer, and a buffer layer. The emission layer includes a light emitting material. The buffer layer is disposed between and in electrical communication with the electrode and the emission layer and includes a triarylamine hole transport material and an electron acceptor material. The buffer layer optionally includes one or more of a) a polymeric binder, b) a color converting material, and c) light scattering particles. The buffer layer can also be formed using a polymeric hole transport material having a plurality of triarylamine moieties.
摘要:
Processes for positioning, securing, and repositioning payload assemblies onto floor assemblies are disclosed. In one embodiment, a method includes forming a support structure having a plurality of elongated engagement members, each engagement member including an engagement surface adapted to support a load; forming an adaptable payload assembly that includes a payload member and at least one payload support coupled to the payload member, the payload support being adapted to transmit loads from the payload member to at least one engagement member, the payload support being moveable with the payload member relative to the support structure; and removeably coupling the payload support to at least one of the engagement surfaces of the engagement members. In an alternate embodiment, the engagement surfaces are at least one of approximately flush with and recessed below a lower surface of a panel supported by the support structure.
摘要:
Non-protruding seat track apparatus and methods are disclosed. In one embodiment, a track includes an elongated support having a support surface and an engagement surface. The support surface is adapted to engage a lower surface of a floor panel, and the engagement surface is adapted to be coupled to a payload assembly. The engagement surface is at least one of flush with and recessed below the lower surface of the floor panel when the support surface is engaged with the lower surface. The engagement surface may have at least one of an engagement slot and an attachment aperture disposed therein.
摘要:
A shoe or footwear insert pad is configured to fit over at least part of the forward portion of the sole, extending under the toes and ball of a wearer's foot. The pad has an upper face, a lower face, a forward edge, a rear edge, and inner and outer edges, with the inner and outer edges conforming to the shape of corresponding inner and outer edges of the sole of the footwear. A foot stop bar or rib on the inner face of the pad extends in a selected, at least partially curved path from the inner edge to the outer edge configured to match the curve of the space at the base of a wearer's toes where the toes meet the remainder of the foot. In one example, the position of the foot stop bar on the pad is adjustable for wearers' having different foot sole topographies.